| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |